CRISPR Therapeutics
ISIN CH0334081137
|WKN A2AT0Z
Overview
Description
CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.
Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland
Financials
Key metrics
| Market capitalisation, EUR | 3,795.40 m |
| EPS, EUR | -2.60 |
| P/B ratio | 2.11 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 343.36 m |
| Net income, EUR | -142.09 m |
| Profit margin | -41.38% |
What ETF is CRISPR Therapeutics in?
There are 29 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.07% | Equity United States Small Cap | 1,381 | 0.14% | 48 | +42.91% | A3DQ08 | IE000JNKVS10 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.28% | 8 | +26.32% | A2DWAC | IE00BDGV0746 |
| WisdomTree BioRevolution UCITS ETF USD Acc | 1.12% | Equity World Health Care Social/Environmental Biotech | 89 | 0.45% | 3 | +6.50% | A3CY21 | IE000O8KMPM1 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.07% | Equity United States Small Cap | 1,381 | 0.14% | 150 | +41.92% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.25% | 33 | +37.35% | A2DND0 | IE00BDGV0308 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 3,620 | 0.50% | 62 | +27.96% | WELT0B | IE000FPWSL69 |
| iShares MSCI World Small Cap UCITS ETF | 0.05% | Equity World Small Cap | 3,336 | 0.35% | 4,376 | +30.45% | A2DWBY | IE00BF4RFH31 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity North America Social/Environmental | 1,471 | 0.12% | 184 | +39.22% | A3DJRE | IE000O58J820 |
| L&G Healthcare Breakthrough UCITS ETF USD Acc | 1.57% | Equity World Health Care Innovation | 70 | 0.49% | 60 | +20.53% | A2PM51 | IE00BK5BC677 |
| WisdomTree Megatrends UCITS ETF USD | 0.06% | Equity World Social/Environmental Innovation | 645 | 0.50% | 36 | - | A3EYCN | IE0000902GT6 |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 1.39% | Equity World Health Care Social/Environmental Innovation | 53 | 0.35% | 5 | +13.83% | A3DSGJ | IE000B9PQW54 |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 0.82% | Equity World Health Care Social/Environmental Innovation | 97 | 0.30% | 3 | +16.55% | DBX0R2 | IE000KD0BZ68 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Acc) | 0.00% | Equity World | 3,553 | 0.17% | 2,099 | +31.18% | A1JJTD | IE00B3YLTY66 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.25% | 85 | +37.53% | A2JSD1 | IE00BDGV0415 |
| ARK Innovation UCITS ETF USD Accumulating | 4.19% | Equity World Innovation | 32 | 0.75% | 15 | - | A408AW | IE000GA3D489 |
| SPDR MSCI World Small Cap UCITS ETF | 0.04% | Equity World Small Cap | 3,564 | 0.45% | 904 | +31.52% | A1W56P | IE00BCBJG560 |
| ARK Genomic Revolution UCITS ETF USD Accumulating | 6.14% | Equity World Health Care Innovation | 36 | 0.75% | 4 | - | A408AY | IE000O5M6XO1 |
| Global X Genomics & Biotechnology UCITS ETF | 3.04% | Equity World Health Care Biotech | 42 | 0.50% | 8 | +0.30% | A2QRCP | IE00BM8R0N95 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 5,815 | 0.24% | 327 | +31.85% | A2QL8V | IE00BNG8L385 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Dist) | 0.00% | Equity World | 3,553 | 0.17% | 11 | - | A40F93 | IE000DD75KQ5 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.01% | Equity United States Multi-Factor Strategy | 1,959 | 0.28% | 25 | +27.64% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.07% | Equity United States Small Cap | 1,606 | 0.43% | 2,100 | +38.81% | A0X8SB | IE00B3VWM098 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.40% | Equity United States Health Care Biotech | 214 | 0.35% | 33 | +24.66% | A2JDYM | IE00BDZVHG35 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 3,620 | 0.50% | 331 | +28.36% | WELT0A | IE0001UQQ933 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.40% | Equity United States Health Care Biotech | 214 | 0.35% | 444 | +25.65% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.02% | Equity United States Small Cap | 1,700 | 0.30% | 533 | +40.82% | A12HU5 | IE00BSPLC413 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.03% | Equity World Small Cap | 2,275 | 0.35% | 70 | +30.63% | A3C14G | IE000T9EOCL3 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 1,471 | 0.12% | 26 | +39.48% | A3DJRF | IE000L2ZNB07 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity World Social/Environmental | 5,815 | 0.24% | 432 | +32.07% | A2QL8U | IE00BNG8L278 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.